Advertisement

Tests of vaginal microbicides in the mouse genital herpes model

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Microbicide candidates were selected that have demonstrated activity against sperm or sexually transmitted disease pathogens in vitro, and the efficacy of these agents for preventing vaginal transmission of genital herpes infection was evaluated in the progestin-treated mouse. Each agent was delivered to the vaginas of mice approximately 20 sec prior to delivering a highly infectious herpes simplex virus-2 inoculum. The following agents provided significant protection: anti-HSV monoclonal antibodies III-174 and HSV8, modified bovine β-lactoglobulin (β-69), carrageenan, concanavalin A, chlorhexidine, dextran sulfate (average molecular weight 8,000 and 500,000), fucoidan, neem, nonoxynol-9, polystyrene sulfonate, and povidoneiodine. Two agents, gramicidin and heparan sulfate, though highly effective in vitro, were not protective in vivo at the doses tested.

      Keywords

      References

        • Cohen J
        Women: absent term in the AIDS research equation.
        Science. 1995; 269: 777-780
        • Elias CJ
        • Heise LL
        Challenges for the development of female-controlled vaginal microbicides.
        AIDS. 1994; 8: 1-9
        • Rosenberg MJ
        • Holmes KK
        Virucides in prevention of HIV infection.
        Sex Transm Dis. 1993; 20: 41-44
        • Stein ZA
        HIV prevention: the need for methods women can use.
        Am J Public Health. 1990; 80: 460-462
        • Stone AB
        • Hitchcock PJ
        Vaginal microbicides for preventing the sexual transmission of AIDS.
        AIDS. 1994; 8: S285-S293
      1. Harrison PF Rosenfield A Contraceptive Research and Development. National Academy Press, Washington, DC1996
        • Rosenberg MJ
        • Davidson AJ
        • Chen J
        • Judson FN
        • Douglas JM
        Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms.
        Am J Public Health. 1992; 82: 669-674
        • Whaley KJ
        • Barratt RA
        • Zeitlin L
        • Hoen TE
        • Cone RA
        Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections.
        J Infect Dis. 1993; 168: 1009-1011
        • Moench TR
        • Whaley KJ
        • Mandrell TD
        • Bishop BD
        • Witt CJ
        • Cone RA
        The cat/feline immunodeficiency virus model for transmucosal transmission of AIDS: nonoxynol-9 contraceptive jelly blocks transmission by an infected cell inoculum.
        AIDS. 1993; 7: 797-802
        • Neurath AR
        • Jiang S
        • Strick N
        • Lin K
        • Li YY
        • Debnath AK
        Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV.
        Nature Med. 1996; 2: 230-234
        • Neurath AR
        • Li YY
        • Strick N
        • Jiang S
        A herpesvirus inhibitor from bovine whey.
        Lancet. 1996; 347: 1703-1704
        • Baba M
        • Snoeck R
        • Pauwels R
        • De Clercq E
        Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus.
        Antimicrob Agents Chemother. 1988; 32: 1742-1745
        • Gonzalez ME
        • Alarcon B
        • Carrasco L
        Polysaccharides as antiviral agents: antiviral activity of carrageenan.
        Antimicrob Agents Chemother. 1987; 31: 1388-1393
        • Nisbet IT
        • Graham DM
        • Spicer PE
        • Tibbs G
        Chlorhexidine as an effective agent against Chlamydia trachomatis in vitro and in vivo.
        Antimicrob Agents Chemother. 1979; 16: 855-857
        • Bernstein D
        • Schiff G
        • Echler G
        • Prince A
        • Feller M
        • Briner W
        In vitro virucidal effectiveness of a 0.12% chlorhexidine gluconate mouthrinse.
        J Dent Res. 1990; 69: 874-876
        • Louis SM
        • Pearson RM
        A comparison of the effects of nonoxynol-9 and chlorhexidine on sperm motility.
        Contraception. 1985; 32: 199-205
        • Hennessey TD
        Antibacterial properties of Hibitane.
        J Clin Periodontol. 1977; 4: 36-48
        • Hansen JES
        • Nielsen C
        • Vestergaard BF
        Inhibition of human immunodeficiency virus 1 and herpes simplex virus 1 infectivity with a broad range of lectins.
        Scand J Infect Dis. 1991; 23: 425-430
        • Ito M
        • Barron AL
        Inactivation of herpes simplex virus by concanavalin A.
        J Virol. 1974; 13: 1312-1318
        • Petronio MG
        • Mansi A
        • Gallinelli C
        • Pisani S
        • Seganti L
        • Chiarini F
        In vitro effect of natural and semi-synthetic carbohydrate polymers on Chlamydia trachomatis infection.
        Chemotherapy. 1997; 43: 211-217
        • Oehninger S
        • Clark GF
        • Acosta AA
        • Hodgen GD
        Nature of the inhibitory effect of complex saccharide moieties on the tight binding of human spermatozoa to the human zona pellucida.
        Fertil Steril. 1991; 55: 165-169
        • Bourinbaiar AS
        • Lee-Huang S
        Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.
        Contraception. 1994; 49: 131-137
        • Kuo C-C
        • Grayston T
        Interaction of Chlamydia trachomatis organisms and HeLa 229 cells.
        Infect Immun. 1976; 13: 1103-1109
        • Matthews R
        • Hodgetts S
        • Burnie J
        Preliminary assessment of a human recombinant antibody fragment to hsp90 in murine invasive candidiasis.
        J Infect Dis. 1995; 171: 1668-1671
        • Byrne GI
        • Stephens RS
        • Ada G
        • et al.
        Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J Infect Dis. 168. 1993: 415-420
        • Williamson RA
        • Burioni R
        • Sanna PP
        • Partridge LJ
        • Barbas CF
        • Burton DR
        Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries.
        in: Proc Natl Acad Sci. 90. 1993: 4141-4145
        • Qiao M
        • Macnaughton TB
        • Gowans EJ
        Adsorption and penetration of hepatitis B virus in a nonpermissive cell line.
        Virology. 1994; 210: 356-363
        • Christensen ND
        • Cladel NM
        • Reed CA
        Postattachment neutralization of papillomaviruses by monoclonal and polyclonal antibodies.
        Virology. 1995; 207: 136-142
        • Isojima S
        • Kameda K
        • Tsuji Y
        • Shigeta M
        • Ikeda Y
        • Koyama K
        Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma.
        Am J Reprod Immunol. 1987; 10: 67-78
        • Jones SA
        • Marchitto KS
        • Miller JN
        • Norgard MV
        Monoclonal antibody with hemagglutination, immobilization, and neutralization activities defines an immunodominant, 47,000 mol wt, surface-exposed immunogen of Treponema pallidum.
        J Exp Med. 1984; 160: 1404-1420
        • Moav N
        • Draghi E
        • David A
        • Gold D
        Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity.
        Immunology. 1988; 63: 63-69
        • Smith DG
        • Russell WC
        • Thirkell D
        Adherence of Ureaplasma urealyticum to human epithelial cells.
        Microbiology. 1994; 140: 2893-2898
        • Garg S
        • Doncel G
        • Chabra S
        • Upadhyay SN
        • Talwar GP
        Synergistic spermicidal activity of neem seed extract, reetha saponins and quinine hydrochloride.
        Contraception. 1994; 50: 185-190
        • Shubair M
        • Larsen B
        Growth inhibition of Candida albicans and other medically important yeasts by vaginal contraceptive products.
        Gynecol Obstet Invest. 1990; 29: 67-70
        • Patton DL
        • Wang S-K
        • Kuo C-C
        In vitro activity of nonoxynol-9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis.
        Antimicrob Agents Chemother. 1992; 36: 1478-1482
        • Malkovsky M
        • Newell A
        • Dalgleish AG
        Inactivation of HIV by nonoxynol-9.
        Lancet. 1988; 19: 645
        • Asculai SS
        • Weis MT
        • Rancourt MW
        • Kupferberg AB
        Inactivation of herpes simplex viruses by nonionic surfactants.
        Antimicrob Agents Chemother. 1978; 13: 686-690
        • Cowan ME
        • Cree GE
        A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P.
        Br J Vener Dis. 1973; 49: 65-66
        • Sugarman B
        • Mummaw N
        Effects of antimicrobial agents on growth and chemotaxis of Trichomonas vaginalis.
        Antimicrob Agents Chemother. 1988; 32: 1323-1326
        • Amortegui AJ
        • Melder RJ
        • Meyer MP
        • Singh B
        The effect of chemical intravaginal contraceptives and Betadine on Ureaplasma urealyticum.
        Contraception. 1984; 30: 135-141
        • Foldesy RG
        • Homm RE
        • Levinson SL
        • Hahn DW
        Multiple actions of a novel vaginal contraceptive compound, ORF 13904.
        Fertil Steril. 1986; 45: 550-555
        • Amstey MS
        • Metcalf S
        Effect of povidone-iodine on herpesvirus type 2 in vitro.
        Obstet Gynecol. 1975; 46: 528-529
        • Sokal DC
        • Hermonat PL
        Inactivation of papillomavirus by low concentrations of povidone-iodine.
        Sex Transm Dis. 1995; 22: 22-24
        • Zamora JL
        Chemical and microbiologic characteristics and toxicity of povidone-iodine solutions.
        Am J Surg. 1986; 151: 400-406
        • Eis AM
        • Schneweis KE
        Pathogenesis of genital herpes simplex virus infection in mice.
        Med Microbiol Immunol. 1986; 175: 281-292
        • Richards JT
        • Kern ER
        • Overall JC
        • Glasgow LA
        Differences in neurovirulence among isolates of herpes simplex virus types 1 and 2 in mice using four routes of infection.
        J Infect Dis. 1981; 144: 464-471
        • Walz MA
        • Price RW
        • Hayashi K
        • Katz BJ
        • Notkins AL
        Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.
        J Infect Dis. 1977; 135: 744-752
        • Neyts J
        • De Clercq E
        Effect of polyanionic compounds on intracutaneous and intravaginal herpesvirus infection in mice: impact on the search for vaginal microbicides with anti-HIV activity.
        J Acquired Immune Defic Syndr. 1995; 10: 8-12
        • Whaley KJ
        • Zeitlin L
        • Barratt RA
        • Hoen TE
        • Cone RA
        Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.
        J Infect Dis. 1994; 169: 647-649
        • Zeitlin L
        • Whaley KJ
        • Sanna PP
        • et al.
        Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab′)2 fragments protect mice from vaginal transmission of HSV-2.
        Virology. 1996; 225: 213-215
        • Matthews DE
        • Farewell V
        Using and Understanding Medical Statistics. Karger, Basel1985: 20-38
        • Vorherr H
        • Vorherr UF
        • Mehta P
        • Ulrich JA
        • Messer RH
        Vaginal absorption of povidone-iodine.
        JAMA. 1980; 244: 2628-2629
        • Cone RA
        • Whaley KJ
        Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies.
        Am J Reprod Immunol. 1994; 32: 114-131
        • Roddy RE
        • Cordero M
        • Cordero C
        • Fortney JA
        A dosing study of nonoxynol-9 and genital irritation.
        Int J Sex Transm Dis AIDS. 1993; 4: 165-170
        • Elias CJ
        • Coggins C
        Female-controlled methods to prevent sexual transmission of HIV.
        AIDS. 1996; 10: S43-S51